(For a Reuters live blog on U.S., UK and European stock
markets, click or type LIVE/ in a news window)
* FTSE 100 rises 0.3%, FTSE 250 climbs 0.1%
* BP up 1% after Q2 profit more than doubles to $5.73
billion
* Metal miners rally as copper prices touch two-month highs
Aug 4 (Reuters) - London's FTSE 100 rose on Tuesday, buoyed
by strong results from blue-chip company BP and a surge in metal
miners as commodity prices climbed.
The FTSE 100 index was up 0.3% at 10,886.98 points
by 0905 GMT, while the midcap FTSE 250 inched up 0.1% to
24,244.35 points.
* Shares of BP rose 1% after the oil major reported
second-quarter profit that more than doubled to $5.73 billion
and beat analysts' forecasts, thanks to higher energy prices,
trading and refining margins.
* HSBC ( HSBC ) dipped 1.1%, having hit a record high
earlier in the session, after the bank raised its net interest
income target for this year.
* Industrial metal miners such as Glencore ( GLCNF ) and Rio
Tinto added 4.1% and 2.7%, respectively, as copper
prices touched two-month highs, supported by falling
inventories.
* The broader pan-European STOXX 600 index touched
record highs and U.S. futures rose as an upbeat earnings season
and renewed buying in big U.S. technology stocks offset
uncertainty around the Middle East conflict.
* The FTSE 100 is rebounding after three sessions of
declines, and held below a record high hit last week. The FTSE
250 was trading at a near six-year high.
* Oil prices rose on Tuesday as a diplomatic resolution to
the U.S.-Iran conflict remained uncertain, with Iran's Foreign
Ministry spokesman Esmail Baghaei saying no negotiations with
the U.S. were taking place.
* Among other movers, Travis Perkins jumped 18%
after the building materials supplier reported higher first-half
profit, helped by price increases and cost-cutting measures. It
was the top gainer in the FTSE 250 index.
* Segro ( SEGXF ) gained 0.8% after the British warehouse
landlord accepted a takeover bid by rival U.S. logistics firm
Prologis ( PLD ) in a deal worth up to £14.3 billion ($19.19
billion).
* Smith+Nephew dipped 6.9% after the medical products
maker lowered its revenue growth forecast, hurt by continued
weakness in its U.S. orthopaedics unit.